| Literature DB >> 6098465 |
A G Wildeman, P Sassone-Corsi, T Grundström, M Zenke, P Chambon.
Abstract
A nuclear extract prepared from HeLa cells has been used to study in vitro the transcription of the SV40 early promoter. The deletion of the enhancer results in a strong decrease of transcription, with spermidine and MgCl2 being critical variables in the transcription reactions. Furthermore a competition assay indicates that the stimulation by the enhancer is due to a specific trans-acting factor(s) which acts on it. This factor appears not to interact with SV40 or adenovirus-2 major late upstream (distal) promoter sequences, and its ability to bind to the enhancer is diminished by mutations known to decrease enhancer function in vivo and in vitro.Entities:
Mesh:
Substances:
Year: 1984 PMID: 6098465 PMCID: PMC557828 DOI: 10.1002/j.1460-2075.1984.tb02269.x
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598